 |
|
|
|
|
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Sambamurti K. on PAPER: Deane R. et al., 2012, The binding of amyloid by RAGE has been an interesting development that has long been waiting to... 17 Apr 2012.
|
|
|
 |
|
|
Sambamurti K. on PAPER: Faux NG. et al., 2011, Recommendation Only. 16 Mar 2012.
|
|
|
|
|
|
Bachman D, Granholm-Bentley L, Mintzer J, Sambamurti K. on PAPER: Burns JM. et al., 2011, This is really interesting and goes against the usual interpretation that increased blood... 26 Jul 2011.
|
|
|
|
|
|
Sambamurti K. on PAPER: Wakabayashi T. et al., 2009, This represents a careful and significant study with clean results. It probably explains why... 27 Oct 2009.
|
|
|
|
|
|
Sambamurti K. on PAPER: Lakshmana MK. et al., 2010, This is an exciting finding. 16 Sep 2009.
|
|
|
|
|
|
Sambamurti K. on NEWS: Anne Cataldo, 57, Autophagy Researcher Known for Generous Collegiality, It is impossible to give words to feelings under these conditions. Although my personal... 4 May 2009.
|
|
|
|
|
|
Sambamurti K. on NEWS: ApoE’s Secret Revealed? Protein Promotes Aβ Degradation, Great findings. 13 Jan 2009.
|
|
|
|
|
|
Sambamurti K. on PAPER: Jacobsen JS. et al., 2008, This is a truly exciting study that takes advantage of an Aβ-degrading enzyme to increase Aβ... 25 Jun 2008.
|
|
|
|
|
|
Sambamurti K. on PAPER: Siemers ER. et al., 2007 Nov-Dec, Recommendation Only. 8 Apr 2008.
|
|
|
|
|
|
Sambamurti K. on NEWS: Keystone Drug News: CoMentis BACE Inhibitor Debuts, This will be exciting to watch and follow up. 8 Apr 2008.
|
|
|
|
|
|
Sambamurti K. on LIVE DISCUSSION: How the Other Half Lives—Or the What, How, and Where of the AβPP Intracellular Domain, The role of the cytoplasmic fragment generated by gamma secretase cleavage
in APP... 28 Aug 2006.
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
